Approaches to the Development of a Low-dose Naltrexone Preparation in the Form of a Nasal Spray (Review)
Introduction. Naltrexone hydrochloride belongs to µ-opioid receptor antagonists and is widely used in the treatment of alcohol and drug addiction at an oral dose of 50 mg/day. It is also a blocker of other receptors – opioid growth factor and Toll-like factor, which is especially evident at doses of...
Main Authors: | Yu. M. Domnina, V. V. Suslov, S. A. Kedik, P. O. Volkova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
LLC Center of Pharmaceutical Analytics (LLC «CPHA»)
2021-02-01
|
Series: | Разработка и регистрация лекарственных средств |
Subjects: | |
Online Access: | https://www.pharmjournal.ru/jour/article/view/852 |
Similar Items
-
RATIONALE FOR THE SELECTION OF AUXILIARY COMPONENTS FOR THE NALTREXONE HYDROCHLORIDE NASAL SPRAY
by: Y. M. Domnina, et al.
Published: (2019-01-01) -
Microbiological Estimation of Nasal Spray Containing Naltrexone Hydrochloride
by: Yu. M. Domnina, et al.
Published: (2020-11-01) -
Study of Acute Toxicity and Irritant Effect of Nasal Spray Naltrexone Hydrochloride
by: Yu. M. Domnina, et al.
Published: (2021-05-01) -
Quantitative Determination of Benzalconium Chloride in the Naltrexone Hydrochloride Nasal Spray
by: Yu. M. Domnina, et al.
Published: (2020-11-01) -
Low-Dose Naltrexone (LDN)—Review of Therapeutic Utilization
by: Karlo Toljan, et al.
Published: (2018-09-01)